MedTrace Logo

A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test

NCT01649453 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2013-03-06

No results posted yet for this study

Summary

The study prospectively assesses the change in cancer-specific clinical decisions and outcomes before and after physicians received results from the Pathwork® Tissue of Origin (TOO) Test for patients whose primary site of cancer origin is uncertain.

Conditions

  • Neoplasm Metastasis

Interventions

DEVICE

Pathwork® Tissue of Origin Test

Sponsors & Collaborators

  • Pathwork Diagnostics

    collaborator UNKNOWN

  • Cedar Associates LLC

    lead OTHER

Principal Investigators

  • John Hornberger, MD MS · Cedar Associates LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-01-31
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01649453 on ClinicalTrials.gov